Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.01M | 30.13M | 22.75M | -56.76M | 44.78M |
| Total Depreciation and Amortization | -22.81M | 22.58M | -- | 45.06M | -22.42M |
| Total Amortization of Deferred Charges | -2.97M | 2.94M | -- | 5.55M | -2.78M |
| Total Other Non-Cash Items | -30.03M | -13.61M | 4.46M | 106.49M | -57.89M |
| Change in Net Operating Assets | 13.03M | -12.89M | -- | -28.30M | 94.39M |
| Cash from Operations | 46.24M | 29.14M | 27.21M | 72.04M | 56.08M |
| Capital Expenditure | -10.16M | -7.29M | -6.61M | -10.91M | -10.59M |
| Sale of Property, Plant, and Equipment | 17.20K | 274.10K | 4.80K | 298.50K | 8.30K |
| Cash Acquisitions | -15.84M | 0.00 | -310.50K | -47.50M | -3.45M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.56M | 104.35M | -83.53M | 194.90M | -139.81M |
| Cash from Investing | 62.57M | 97.33M | -90.45M | 136.79M | -153.84M |
| Total Debt Issued | 35.19M | 454.44M | 555.36M | 535.94M | 1.33B |
| Total Debt Repaid | -884.48M | -966.74M | -319.01M | -2.00B | -1.23B |
| Issuance of Common Stock | 471.07M | -- | 62.60M | 71.22M | 285.26M |
| Repurchase of Common Stock | -- | -371.57M | -- | -270.89M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.73M | -33.81M | -3.72M | -4.63M | -76.09M |
| Other Financing Activities | -410.01M | 405.23M | -375.75M | 263.66M | -317.71M |
| Cash from Financing | -119.85M | -100.00M | -14.28M | -198.85M | -66.80M |
| Foreign Exchange rate Adjustments | -1.60M | 1.30M | 681.80K | 2.06M | -3.24M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.65M | 27.76M | -76.83M | 12.04M | -167.80M |